Gastroenterology Education and CPD for trainees and specialists » Weight-Based Dosing Best for New HCV Drug (CME/CE)

- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

Weight-Based Dosing Best for New HCV Drug (CME/CE)

(MedPage Today) — When given in doses based on weight, an investigational prodrug of ribavirin had efficacy comparable to ribavirin in chronic hepatitis C but with less hemolytic anemia, researchers reported.

Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com